Cargando…

Evaluation of the Potential Pharmacokinetic Interactions Between Vixotrigine and an Oral Contraceptive

BACKGROUND AND OBJECTIVE: Vixotrigine is a voltage- and use-dependent sodium channel blocker in development for neuropathic pain management. This study evaluated the effect of coadministration of vixotrigine (metabolized primarily via uridine diphosphate-glucuronosyltransferases) and an oral contrac...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhao, Yuan, Versavel, Mark, Tidemann-Miller, Beth, Christmann, Romy, Naik, Himanshu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer International Publishing 2020
Materias:	Original Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7359159/ https://www.ncbi.nlm.nih.gov/pubmed/32564301 http://dx.doi.org/10.1007/s40261-020-00931-5

Ejemplares similares

Safety, Tolerability and Pharmacokinetics of Single and Repeat Doses of Vixotrigine in Healthy Volunteers
por: Naik, Himanshu, et al.
Publicado: (2020)

Design of Phase 3 Studies Evaluating Vixotrigine for Treatment of Trigeminal Neuralgia
por: Kotecha, Mona, et al.
Publicado: (2020)

Efficacy and safety of vixotrigine in idiopathic or diabetes-associated painful small fibre neuropathy (CONVEY): a phase 2 placebo-controlled enriched-enrolment randomised withdrawal study
por: Faber, Catharina G., et al.
Publicado: (2023)

Effect of Prucalopride on the Pharmacokinetics of Oral Contraceptives in Healthy Women
por: Van de Velde, Vera, et al.
Publicado: (2013)

Evaluation of the Effect of Tofacitinib on the Pharmacokinetics of Oral Contraceptive Steroids in Healthy Female Volunteers
por: Menon, Sujatha, et al.
Publicado: (2016)

Lack of pharmacokinetic interaction between the HIV‐1 maturation inhibitor GSK3640254 and combination oral contraceptives in healthy women
por: Pene Dumitrescu, Teodora, et al.
Publicado: (2021)

Survey of pharmacists and physicians on drug interactions between combined oral contraceptives and broad-spectrum antibiotics
por: Masters, Kelly P., et al.
Publicado: (2009)

Dolutegravir Has No Effect on the Pharmacokinetics of Oral Contraceptives With Norgestimate and Ethinyl Estradiol
por: Song, Ivy H., et al.
Publicado: (2015)

Pharmacokinetic Interactions between the Hormonal Emergency Contraception, Levonorgestrel (Plan B), and Efavirenz
por: Carten, Monica L., et al.
Publicado: (2012)

Interactions between clinically used drugs and oral contraceptives.
por: Bolt, H M
Publicado: (1994)

Pharmacokinetic overview of ethinyl estradiol dose and bioavailability using two transdermal contraceptive systems and a standard combined oral contraceptive
por: Hofmann, Birte, et al.
Publicado: (2014)

551. MK-8591 Does Not Alter the Pharmacokinetics of the Oral Contraceptives Ethinyl Estradiol and Levonorgestrel
por: Ankrom, Wendy, et al.
Publicado: (2018)

A Multi-Center, Open-Label, Pharmacokinetic Drug Interaction Study of Erenumab and a Combined Oral Contraceptive in Healthy Females
por: Xu, Yang, et al.
Publicado: (2019)

Effects of Lemborexant on the Pharmacokinetics of Oral Contraceptives: Results From a Phase 1 Drug‐Drug Interaction Study in Healthy Females
por: Landry, Ishani, et al.
Publicado: (2021)

An interactive website for informed contraception choice: randomised evaluation of Contraception Choices
por: Stephenson, Judith, et al.
Publicado: (2020)

Evaluation of extended and continuous use oral contraceptives
por: Wright, Kristen Page, et al.
Publicado: (2008)

Evaluation of Potential Drug–Drug Interaction Between Delayed‐Release Dimethyl Fumarate and a Commonly Used Oral Contraceptive (Norgestimate/Ethinyl Estradiol) in Healthy Women
por: Zhu, Bing, et al.
Publicado: (2017)

Pharmacokinetic Interaction Between the MEK1/MEK2 Inhibitor Trametinib and Oral Contraceptives Containing Norethindrone and Ethinyl Estradiol in Female Patients With Solid Tumors
por: Arkenau, Hendrik‐Tobias, et al.
Publicado: (2022)

Effect of Protease Inhibitors on Steady-State Pharmacokinetics of Oral Norethindrone Contraception in HIV-Infected Women
por: Atrio, Jessica, et al.
Publicado: (2014)

The effects of vilaprisan on the pharmacodynamics and pharmacokinetics of a combined oral contraceptive—A randomized controlled trial
por: Schultze‐Mosgau, Marcus‐Hillert, et al.
Publicado: (2020)

Non-Contraceptive Benefits of Oral Hormonal Contraceptives
por: Schindler, Adolf E
Publicado: (2012)

Lack of effect of oral cabotegravir on the pharmacokinetics of a levonorgestrel/ethinyl oestradiol‐containing oral contraceptive in healthy adult women
por: Trezza, Christine, et al.
Publicado: (2017)

Infant behavioural effects of smartphone interrupted parent‐infant interaction
por: Tidemann, Ida T., et al.
Publicado: (2022)

Population pharmacokinetics of artesunate and dihydroartemisinin following single- and multiple-dosing of oral artesunate in healthy subjects
por: Tan, Beesan, et al.
Publicado: (2009)

Oral contraceptives alter oral health
por: Saini, Rajiv, et al.
Publicado: (2010)

Clinical Pharmacokinetics and Safety of ALZ-801, a Novel Prodrug of Tramiprosate in Development for the Treatment of Alzheimer’s Disease
por: Hey, John A., et al.
Publicado: (2017)

Population Pharmacokinetic Meta-Analysis of Vortioxetine in Healthy Individuals
por: Areberg, Johan, et al.
Publicado: (2014)

Effect of exenatide on the pharmacokinetics of a combination oral contraceptive in healthy women: an open-label, randomised, crossover trial
por: Kothare, Prajakti A, et al.
Publicado: (2012)

Atogepant Has No Clinically Relevant Effects on the Pharmacokinetics of an Ethinyl Estradiol/Levonorgestrel Oral Contraceptive in Healthy Female Participants
por: Ankrom, Wendy, et al.
Publicado: (2020)

Oral contraceptives and breast cancer.
por: Jick, S. S., et al.
Publicado: (1989)

Oral contraceptives and breast cancer.
por: Asscher, A. W.
Publicado: (1987)

Malignant melanoma and oral contraceptives
por: Kay, C. R.
Publicado: (1981)

Oral contraceptives and breast cancer.
por: Chilvers, C. E., et al.
Publicado: (1990)

Hepatocellular carcinoma and oral contraceptives.
por: Henderson, B. E., et al.
Publicado: (1983)

Oral contraceptives and malignant melanoma.
por: Hannaford, P. C., et al.
Publicado: (1991)

Oral Contraceptives and Breast Cancer
por: Kinlen, L.J.
Publicado: (1993)

Evaluation of the Pharmacokinetic Interaction between Lesogaberan (AZD3355) and Esomeprazole in Healthy Subjects
por: Niazi, Mohammad, et al.
Publicado: (2012)

The cytokine language of monocytes and macrophages in systemic sclerosis
por: Christmann, Romy B, et al.
Publicado: (2010)

Evaluation of Pharmacokinetics, Safety, and Drug‐Drug Interactions of an Oral Suspension of Edaravone in Healthy Adults
por: Shimizu, Hidetoshi, et al.
Publicado: (2021)

Improving combined contraceptive pill/oral contraceptives prescribing in general practice
por: Russell, Sophie, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_d9hfdfjsp4ovj82b23d9pf2t1a